Glaxo SmithKline Pharmaceuticals said a substantial drop in standalone net profit for the quarter ended March 2014. During the quarter, the profit of the company declined 42.88% to Rs 965.40 million from Rs 1,690.10 million in the same quarter previous year.
Net sales for the quarter declined marginally 4.24% to Rs 6,098.50 million, compared with Rs 6,368.80 million for the prior year period.
Earnings per share for the quarter stood at Rs 11.40, registering 43.00% decline over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Mar - 14 | Mar - 13 | %Change |
| Net Sales | 6,098.50 | 6,368.80 | (4.24) |
| Net Profit | 965.40 | 1,690.10 | (42.88) |
| Basic EPS | 11.40 | 20.00 | (43.00) |
Shares of the company declined Rs 13.1, or 0.52%, to trade at Rs 2,495.00. The total volume of shares traded was 3,081 at the BSE (2.43 p.m., Thursday).
